Emergency department presentations for chest complaints after mRNA COVID-19 vaccinations in children and adolescents.

ABSTRACT:

Objective

To investigate characteristics and management of children presenting with chest complaints to a tertiary paediatric ED post-mRNA COVID-19 vaccine.

Methods

This was a retrospective medical record review with data linkage to the Australian Immunisation Register. The study setting was the Royal Children's Hospital, Melbourne, Australia. Children <18 years who had a troponin blood test performed in hospital within 14 days of receiving mRNA COVID-19 vaccination were included. Elevated troponin and myocarditis or pericarditis as per Brighton criteria was the primary outcome. Vaccination status, length of stay, investigations and clinical management were secondary outcomes.

Results

Six hundred and ten patients had a troponin test in 13 months. After exclusion of tr

SUBMITTER: Parr M 

PROVIDER: S-EPMC10953413 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature